Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1-(1,3-Dioxaindan-5-yl)-2-bromoethan-1-one → Methyl [2-[(1,3-benzodioxol-5-yl)carbonyl]-6-chloro-1H-indol-3-yl]acetate
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1-(1,3-Dioxaindan-5-yl)-2-bromoethan-1-one | HCID 243777 | — |
| 반응물 | methyl [6-chloro-2-[(5,6,7,8-tetrahydroisoquinolin-3-yl)carbonyl]-1H-indol-3-yl]acetate | HCID 9908023 | — |
| 생성물 | Methyl [2-[(1,3-benzodioxol-5-yl)carbonyl]-6-chloro-1H-indol-3-yl]acetate | HCID 9951334 | — |
반응 단계
The title compound was prepared according to the procedure described in step 2 of Example 1 from 5-bromoacetyl-1,3-benzodioxole (J.Med. Chem., 1977, 20, 394) and methyl trans-4-chloro-2-[(phenylsulfonyl)amino]cinnamate (Example 1, step 1).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US06303628B1 |
| 출처 데이터셋 | uspto-grants-2001_10 |
| ORD ID | ord-ae9addeab3914caabee7f48187873a82 |
| 출처 메모 | uspto-grants-2001_10 |